524717-BOM

Titan Bio-Tech Ltd.

416.90-2.1 (-0.50%)
27 Jul, 12:00 AM

Annual Reports and Financial Documents

Titan Bio-Tech Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Titan Bio-Tech Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
  • Press Release / Media Release (Revised)25 Jun 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
    Intimation for loss of shares by shareholder which have already been transferred earlier to Investor Education Protection Fund.
  • Closure of Trading Window23 Jun 2026
    Closure of Trading Window
    Closure of trading window
  • Newspaper Publication1 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper publication of the Audited Financial Results (Standalone & Consolidated) for fourth quarter and year ended March 31, 2026
  • General30 May 2026
    Re-Appointment Of Cost Auditor For Financial Year 2026-2027
    Intimation for re-appointment of Cost Auditor of the Company
  • Dividend30 May 2026
    Corporate Action-Board to consider Dividend
    The Board of Director of the Company has recommended a dividend of Rs. 0.50 paisa per Equity Share
  • Outcome of Board Meeting30 May 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Of Titan Biotech Limited Held Today I.E. 30Th May, 2026
    Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors, at its meeting held today i.e. ....
  • Board Meeting20 May 2026
    Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended March 31, 2026 And To Recommend Dividend, If Any, On The Equity Shares Of The Company For The Financial Year 2025-26.
    Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the audited financial results ....
  • General6 May 2026
    Intimation Regarding Second 100 Days Campaign - 'Saksham Niveshak'
    Second 100 days Campaign under Saksham Niveshak Yojna
  • Press Release / Media Release6 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Newspaper publication regarding special window for re-lodgement of transfer request and dematerialisation of physical shares.
  • Reg.24(A)-Annual Secretarial Compliance4 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report for the financial year ending March 31, 2026
  • Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A28 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  • Press Release / Media Release23 Apr 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Newspaper advertisement for Loss of Share Certificate
  • Press Release / Media Release6 Apr 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Newspaper advertisement for Loss of Share Certificate
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20184 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance Certificate under Regn 74(5) of SEBI (DP) Regulations, 2018
  • Closure of Trading Window26 Mar 2026
    Closure of Trading Window
    Closure of Trading Window
  • General27 Feb 2026
    Intimation Of Credit Confirmation Of Equity Shares From Depositories With Regard To Sub-Division / Split Of Equity Shares Of The Company
    Intimation pertaining to credit confirmation of Equity Shares from the depositories regarding Sub-Division/Split of Equity Shares of the Company.
  • General17 Feb 2026
    Re-Lodgement Of Transfer Requests Of Physical Shares
    Please find attached herewith report for the period from 01.01.2026 to 06.01.2026 pertaining to re-lodgment of transfer of physical shares
  • Newspaper Publication13 Feb 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of the unaudited financial Results (Standalone & Consolidated) for third quarter and nine months ended December, 2025
  • Outcome of Board Meeting12 Feb 2026
    Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2025
    Outcome of the board meeting held on 12th February, 2026.

Frequently Asked Questions

Where can I download the annual report of Titan Bio-Tech Ltd.?
Annual reports of Titan Bio-Tech Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Titan Bio-Tech Ltd.?
Quarterly earnings results and presentations of Titan Bio-Tech Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Titan Bio-Tech Ltd. publish earnings call transcripts?
Earnings call transcripts of Titan Bio-Tech Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Titan Bio-Tech Ltd.?
Investor presentations and annual day presentations of Titan Bio-Tech Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Titan Bio-Tech Ltd.?
Corporate announcements and regulatory filings of Titan Bio-Tech Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Titan Bio-Tech Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Titan Bio-Tech Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Titan Bio-Tech Ltd.?
The ISIN (International Securities Identification Number) of Titan Bio-Tech Ltd. is INE150C01029. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Titan Bio-Tech Ltd. listed?
Titan Bio-Tech Ltd. is listed on NSE and BSE. The NSE symbol is 524717-BOM and the BSE code is -.
Where can I find the shareholding pattern of Titan Bio-Tech Ltd.?
The quarterly shareholding pattern of Titan Bio-Tech Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Titan Bio-Tech Ltd. on Sharpely?
Share price data for Titan Bio-Tech Ltd. is updated as of 27 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.